Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus, covering 2022-06-01 to 2022-06-01. Get the full timeline:
Most recent: FDA Approved: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS — Original Application (VESPYR BRANDS LLC)